Cargando…

Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic

ETHNOPHARMACOLOGICAL RELEVANCE: There are plant species used in the Mexican traditional medicine for the empirical treatment of anxiety and depression. AIM OF THE STUDY: This work assessed the prevalence of self-medication with medicinal plants and the prevalence of the concomitant use of prescribed...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso-Castro, Angel Josabad, Ruiz-Padilla, Alan Joel, Ortiz-Cortes, Miriam, Carranza, Eleazar, Ramírez-Morales, Marco Antonio, Escutia-Gutiérrez, Raymundo, Ruiz-Noa, Yeniley, Zapata-Morales, Juan Ramon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387533/
https://www.ncbi.nlm.nih.gov/pubmed/33610705
http://dx.doi.org/10.1016/j.jep.2021.113952
_version_ 1784770037812297728
author Alonso-Castro, Angel Josabad
Ruiz-Padilla, Alan Joel
Ortiz-Cortes, Miriam
Carranza, Eleazar
Ramírez-Morales, Marco Antonio
Escutia-Gutiérrez, Raymundo
Ruiz-Noa, Yeniley
Zapata-Morales, Juan Ramon
author_facet Alonso-Castro, Angel Josabad
Ruiz-Padilla, Alan Joel
Ortiz-Cortes, Miriam
Carranza, Eleazar
Ramírez-Morales, Marco Antonio
Escutia-Gutiérrez, Raymundo
Ruiz-Noa, Yeniley
Zapata-Morales, Juan Ramon
author_sort Alonso-Castro, Angel Josabad
collection PubMed
description ETHNOPHARMACOLOGICAL RELEVANCE: There are plant species used in the Mexican traditional medicine for the empirical treatment of anxiety and depression. AIM OF THE STUDY: This work assessed the prevalence of self-medication with medicinal plants and the prevalence of the concomitant use of prescribed psychiatric drugs and medicinal plants for treating symptoms associated with anxiety and depression during the Covid-19 lockdown in Mexico. MATERIALS AND METHODS: The suspected adverse reactions associated with drug-herb interactions were assessed. The factors associated with self-medication, the concomitant use of herb-drug combinations, and the presence of adverse reactions due their combined use is also reported. The study was descriptive and cross-sectional using an online questionnaire conducted among population with symptoms associated with anxiety and depression (n = 2100) from seven states of central-western Mexico. RESULTS: The prevalence of the use of herbs (61.9%) and the concomitant use of drug-herb combinations (25.3%) were associated with being diagnosed with mental illness [OR:2.195 (1.655–2.912)] and the use of psychiatric medications [OR:307.994 (178.609–531.107)], respectively. The presence of adverse reactions (n = 104) by the concomitant use of drug-herb combinations was associated with being unemployed [p = 0.004, OR: 3.017 (1.404–6.486)]. CONCLUSION: Health professionals should be aware if their patients concomitantly use medicinal plants and psychiatric drugs. Public health campaigns should promote the possible adverse reactions that might produce the concomitant use of drug-herb combinations for mental illnesses.
format Online
Article
Text
id pubmed-9387533
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-93875332022-08-18 Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic Alonso-Castro, Angel Josabad Ruiz-Padilla, Alan Joel Ortiz-Cortes, Miriam Carranza, Eleazar Ramírez-Morales, Marco Antonio Escutia-Gutiérrez, Raymundo Ruiz-Noa, Yeniley Zapata-Morales, Juan Ramon J Ethnopharmacol Article ETHNOPHARMACOLOGICAL RELEVANCE: There are plant species used in the Mexican traditional medicine for the empirical treatment of anxiety and depression. AIM OF THE STUDY: This work assessed the prevalence of self-medication with medicinal plants and the prevalence of the concomitant use of prescribed psychiatric drugs and medicinal plants for treating symptoms associated with anxiety and depression during the Covid-19 lockdown in Mexico. MATERIALS AND METHODS: The suspected adverse reactions associated with drug-herb interactions were assessed. The factors associated with self-medication, the concomitant use of herb-drug combinations, and the presence of adverse reactions due their combined use is also reported. The study was descriptive and cross-sectional using an online questionnaire conducted among population with symptoms associated with anxiety and depression (n = 2100) from seven states of central-western Mexico. RESULTS: The prevalence of the use of herbs (61.9%) and the concomitant use of drug-herb combinations (25.3%) were associated with being diagnosed with mental illness [OR:2.195 (1.655–2.912)] and the use of psychiatric medications [OR:307.994 (178.609–531.107)], respectively. The presence of adverse reactions (n = 104) by the concomitant use of drug-herb combinations was associated with being unemployed [p = 0.004, OR: 3.017 (1.404–6.486)]. CONCLUSION: Health professionals should be aware if their patients concomitantly use medicinal plants and psychiatric drugs. Public health campaigns should promote the possible adverse reactions that might produce the concomitant use of drug-herb combinations for mental illnesses. Elsevier B.V. 2021-05-23 2021-02-18 /pmc/articles/PMC9387533/ /pubmed/33610705 http://dx.doi.org/10.1016/j.jep.2021.113952 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Alonso-Castro, Angel Josabad
Ruiz-Padilla, Alan Joel
Ortiz-Cortes, Miriam
Carranza, Eleazar
Ramírez-Morales, Marco Antonio
Escutia-Gutiérrez, Raymundo
Ruiz-Noa, Yeniley
Zapata-Morales, Juan Ramon
Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic
title Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic
title_full Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic
title_fullStr Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic
title_full_unstemmed Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic
title_short Self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of Mexico during the Covid-19 pandemic
title_sort self-treatment and adverse reactions with herbal products for treating symptoms associated with anxiety and depression in adults from the central-western region of mexico during the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387533/
https://www.ncbi.nlm.nih.gov/pubmed/33610705
http://dx.doi.org/10.1016/j.jep.2021.113952
work_keys_str_mv AT alonsocastroangeljosabad selftreatmentandadversereactionswithherbalproductsfortreatingsymptomsassociatedwithanxietyanddepressioninadultsfromthecentralwesternregionofmexicoduringthecovid19pandemic
AT ruizpadillaalanjoel selftreatmentandadversereactionswithherbalproductsfortreatingsymptomsassociatedwithanxietyanddepressioninadultsfromthecentralwesternregionofmexicoduringthecovid19pandemic
AT ortizcortesmiriam selftreatmentandadversereactionswithherbalproductsfortreatingsymptomsassociatedwithanxietyanddepressioninadultsfromthecentralwesternregionofmexicoduringthecovid19pandemic
AT carranzaeleazar selftreatmentandadversereactionswithherbalproductsfortreatingsymptomsassociatedwithanxietyanddepressioninadultsfromthecentralwesternregionofmexicoduringthecovid19pandemic
AT ramirezmoralesmarcoantonio selftreatmentandadversereactionswithherbalproductsfortreatingsymptomsassociatedwithanxietyanddepressioninadultsfromthecentralwesternregionofmexicoduringthecovid19pandemic
AT escutiagutierrezraymundo selftreatmentandadversereactionswithherbalproductsfortreatingsymptomsassociatedwithanxietyanddepressioninadultsfromthecentralwesternregionofmexicoduringthecovid19pandemic
AT ruiznoayeniley selftreatmentandadversereactionswithherbalproductsfortreatingsymptomsassociatedwithanxietyanddepressioninadultsfromthecentralwesternregionofmexicoduringthecovid19pandemic
AT zapatamoralesjuanramon selftreatmentandadversereactionswithherbalproductsfortreatingsymptomsassociatedwithanxietyanddepressioninadultsfromthecentralwesternregionofmexicoduringthecovid19pandemic